Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam combined with sevoflurane vs propofol for general anesthesia with endotracheal intubation
ChiCTR2200061217Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Perioperative efficacy. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200061217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061217.